US Patent 11959486 Stable liquid formulation of AMG 416 (etelcalcetide)

Is a

Patent

Patent attributes

Patent Applicant

Amgen

Current Assignee

Amgen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

119594860

Patent Inventor Names

Qun Yin0

Derek Maclean0

Date of Patent

April 16, 2024

Patent Application Number

174000440

Date Filed

August 11, 2021

Patent Citations

‌

US Patent 8999932 Therapeutic agents for reducing parathyroid hormone levels

‌

US Patent 9278995 Therapeutic agents for reducing parathyroid hormone levels

‌

US Patent 9701712 Therapeutic agents for reducing parathyroid hormone levels

‌

US Patent 10344765 Stable liquid formulation of AMG 416 (etelcalcetide)

‌

US Patent 9820938 Stable liquid formulation of AMG 416 (etelcalcetide)

‌

US Patent 6846911 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian CD97 α subunit

‌

US Patent 7265092 Pharmaceutical formulation

‌

US Patent 8067532 Modifications of peptide compositions to increase stability and delivery efficiency

...

Patent Primary Examiner

CPC Code

Patent abstract

A liquid formulation comprising a peptide agonist of the calcium sensing receptor and method of preparing and using the formulation are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 11959486 Stable liquid formulation of AMG 416 (etelcalcetide)

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11959486 Stable liquid formulation of AMG 416 (etelcalcetide)